StockData
HUTCHMED (China) Ltd logo

HUTCHMED (China) Ltd (HCM) stock

HCMNasdaqPharmaceutical PreparationsAlso trades as HMDCF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 5, 2026Score 5/30
$13.99−0.41 (-2.85%)

Close on Nov 18, 2026Market cap $2.44BP/E 5.4Yield –

HUTCHMED (China) r&d expenses

Research and development expenses are spending on new products and technology.

HUTCHMED (China)'s R&D Expenses for the twelve months ending Dec 31, 2019 was $138.19M, up 21.0% year over year. For fiscal 2025 it was $148.30M, down 30.1% from the year before. Over ten years it grew 12.1% a year on average. The highest annual figure on record is $386.89M in fiscal 2022.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$148.30M-30.1%
FY2024Dec 31, 2024$212.11M-29.8%
FY2023Dec 31, 2023$302.00M-21.9%
FY2022Dec 31, 2022$386.89M+29.4%
FY2021Dec 31, 2021$299.09M+71.1%
FY2020Dec 31, 2020$174.78M+26.5%
FY2019Dec 31, 2019$138.19M+21.0%
FY2018Dec 31, 2018$114.16M+51.2%
FY2017Dec 31, 2017$75.52M+12.9%
FY2016Dec 31, 2016$66.87M+41.2%
FY2015Dec 31, 2015$47.37M+58.3%
FY2014Dec 31, 2014$29.91M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2019Dec 31, 2019$37.46M+47.3%
Q3 FY2019Sep 30, 2019$31.45M+9.7%
Q2 FY2019Jun 30, 2019$36.01M+14.7%
Q1 FY2019Mar 31, 2019$33.28M+16.1%
Q4 FY2018Dec 31, 2018$25.43M–
Q3 FY2018Sep 30, 2018$28.68M–
Q2 FY2018Jun 30, 2018$31.39M–
Q1 FY2018Mar 31, 2018$28.66M–

More HUTCHMED (China) figures

See a number that looks wrong?